(GLP 1 agonists OR dual GLP 1/GIP agonist OR (GLP 1 agonists AND dual GLP 1/GIP agonist)) AND diabetes mellitus type 2 AND (cardiovascular effects OR cardiovascular outcomes). The gene discussed is GIP; the disease is type 2 diabetes mellitus.